OncoTargets and Therapy, 2019 · DOI: http://doi.org/10.2147/OTT.S232100 · Published: December 1, 2019
This study investigates the role of miR-26a-5p in osteosarcoma cells. The researchers found that miR-26a-5p is highly expressed in osteosarcoma cell lines compared to noncancerous cells. This suggests that miR-26a-5p might be involved in the progression of osteosarcoma. The study further shows that overexpression of miR-26a-5p promotes cell proliferation and migration, but inhibits cell apoptosis. Conversely, reducing miR-26a-5p expression has the opposite effects. This indicates that miR-26a-5p promotes cell proliferation, migration, but inhibit apoptosis of U2OS. Researchers found that miR-26a-5p directly targets HOXA5 in U2OS cells. Overexpression of HOXA5 reversed the effects of miR-26a-5p on cell proliferation, migration, and apoptosis. These findings suggest that miR-26a-5p promotes proliferation and migration, but inhibits apoptosis of osteosarcoma cells by targeting HOXA5.
miR-26a-5p could serve as a novel therapeutic target for osteosarcoma treatment.
Targeting miR-26a-5p may improve the sensitivity of osteosarcoma cells to chemotherapeutic drugs like paclitaxel.
Further exploration of the HOXA5 pathway may provide new insights into osteosarcoma development.